These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
174 related items for PubMed ID: 10520799
21. Life-threatening ventricular arrhythmias due to transient or correctable causes: high risk for death in follow-up. Wyse DG, Friedman PL, Brodsky MA, Beckman KJ, Carlson MD, Curtis AB, Hallstrom AP, Raitt MH, Wilkoff BL, Greene HL, AVID Investigators. J Am Coll Cardiol; 2001 Nov 15; 38(6):1718-24. PubMed ID: 11704386 [Abstract] [Full Text] [Related]
23. A comparison of the AVID and DAVID trials of implantable defibrillators. Sharma A, Epstein AE, Herre JM, Klein RC, Platia EV, Wilkoff B, Ledingham RB, Greene HL, Hallstrom AP, DAVID Investigators. Am J Cardiol; 2005 Jun 15; 95(12):1431-5. PubMed ID: 15950565 [Abstract] [Full Text] [Related]
25. Potential impact of antiarrhythmic drugs versus implantable defibrillators on the management of ventricular arrhythmias: the Midlands trial of empirical amiodarone versus electrophysiologically guided intervention and cardioverter implant registry data. Pathmanathan RK, Lau EW, Cooper J, Newton L, Skehan JD, Garratt CJ, Griffith MJ. Heart; 1998 Jul 15; 80(1):68-70. PubMed ID: 9764063 [Abstract] [Full Text] [Related]
26. New primary prevention trials of sudden cardiac death in patients with left ventricular dysfunction: SCD-HEFT and MADIT-II. Klein H, Auricchio A, Reek S, Geller C. Am J Cardiol; 1999 Mar 11; 83(5B):91D-97D. PubMed ID: 10089848 [Abstract] [Full Text] [Related]
28. Amiodarone, Lidocaine, or Placebo in Out-of-Hospital Cardiac Arrest. Kudenchuk PJ, Brown SP, Daya M, Rea T, Nichol G, Morrison LJ, Leroux B, Vaillancourt C, Wittwer L, Callaway CW, Christenson J, Egan D, Ornato JP, Weisfeldt ML, Stiell IG, Idris AH, Aufderheide TP, Dunford JV, Colella MR, Vilke GM, Brienza AM, Desvigne-Nickens P, Gray PC, Gray R, Seals N, Straight R, Dorian P, Resuscitation Outcomes Consortium Investigators. N Engl J Med; 2016 May 05; 374(18):1711-22. PubMed ID: 27043165 [Abstract] [Full Text] [Related]
29. Determinants of recurrent ventricular arrhythmia or death in 300 consecutive patients with ischemic heart disease who experienced aborted sudden death: data from the Leiden out-of-hospital cardiac arrest study. Kiès P, Boersma E, Bax JJ, van der Burg AE, Bootsma M, van Erven L, van der Wall EE, Schalij MJ. J Cardiovasc Electrophysiol; 2005 Oct 05; 16(10):1049-56. PubMed ID: 16191114 [Abstract] [Full Text] [Related]
31. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study. Connolly SJ, Hallstrom AP, Cappato R, Schron EB, Kuck KH, Zipes DP, Greene HL, Boczor S, Domanski M, Follmann D, Gent M, Roberts RS. Eur Heart J; 2000 Dec 05; 21(24):2071-8. PubMed ID: 11102258 [Abstract] [Full Text] [Related]
32. [Long-term outcome of pharmacological and nonpharmacological treatment for ventricular arrhythmias]. Ohnishi S, Kasanuki H. J Cardiol; 2000 Mar 05; 35 Suppl 1():75-84. PubMed ID: 10834174 [Abstract] [Full Text] [Related]
33. Admission predictors of in-hospital mortality and subsequent long-term outcome in survivors of ventricular fibrillation out-of-hospital cardiac arrest: a population-based study. Bunch TJ, West CP, Packer DL, Panutich MS, White RD. Cardiology; 2004 Mar 05; 102(1):41-7. PubMed ID: 14988618 [Abstract] [Full Text] [Related]
34. [Use of implantable cardioverter defibrillators in the secondary prevention of malignant ventricular arrhythmias: lessons from large studies]. Anadolu Kardiyol Derg; 2001 Mar 05; 1(1):43-7, AXIV. PubMed ID: 12132492 [Abstract] [Full Text] [Related]
35. Predictors of device activation for ventricular arrhythmias and survival in patients with implantable pacemakers/defibrillators. CADENCE Investigators. Reiter MJ, Fain ES, Senelly KM, Robertson AD. Pacing Clin Electrophysiol; 1994 Sep 05; 17(9):1487-98. PubMed ID: 7991419 [Abstract] [Full Text] [Related]
36. Are lipid-lowering drugs also antiarrhythmic drugs? An analysis of the Antiarrhythmics versus Implantable Defibrillators (AVID) trial. Mitchell LB, Powell JL, Gillis AM, Kehl V, Hallstrom AP, AVID Investigators. J Am Coll Cardiol; 2003 Jul 02; 42(1):81-7. PubMed ID: 12849664 [Abstract] [Full Text] [Related]
37. Canadian implantable defibrillator study: what does it mean after the antiarrhythmics versus implantable defibrillators trial? Subramanian VA, Patel NU. Curr Cardiol Rep; 2000 Nov 02; 2(6):489-91. PubMed ID: 11060575 [No Abstract] [Full Text] [Related]
38. Implantable cardioverter-defibrillators for treatment of sustained ventricular arrhythmias in patients with Chagas' heart disease: comparison with a control group treated with amiodarone alone. Gali WL, Sarabanda AV, Baggio JM, Ferreira LG, Gomes GG, Marin-Neto JA, Junqueira LF. Europace; 2014 May 02; 16(5):674-80. PubMed ID: 24481778 [Abstract] [Full Text] [Related]
39. Cardiac Resynchronization Therapy Reduces Ventricular Arrhythmias in Primary but Not Secondary Prophylactic Implantable Cardioverter Defibrillator Patients: Insight From the Resynchronization in Ambulatory Heart Failure Trial. Sapp JL, Parkash R, Wells GA, Yetisir E, Gardner MJ, Healey JS, Thibault B, Sterns LD, Birnie D, Nery PB, Sivakumaran S, Essebag V, Dorian P, Tang AS. Circ Arrhythm Electrophysiol; 2017 Mar 02; 10(3):. PubMed ID: 28292754 [Abstract] [Full Text] [Related]
40. The Dublin cardiac arrest registry: temporal improvement in survival from out-of-hospital cardiac arrest reflects improved pre-hospital emergency care. Margey R, Browne L, Murphy E, O'Reilly M, Mahon N, Blake G, McCann H, Sugrue D, Galvin J. Europace; 2011 Aug 02; 13(8):1157-65. PubMed ID: 21474456 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]